中東・アフリカの眼科市場
Market Size in USD Billion
CAGR :
% 
USD
3.12 Billion
USD
4.42 Billion
2024
2032
 予測期間 |
2025 –2032 |
 市場規模（基準年） |
USD 3.12 Billion |
 Market Size (Forecast Year) |
USD 4.42 Billion |
 CAGR |
% |
| 主要市場プレーヤー |
中東およびアフリカの眼科市場のセグメンテーション、製品別（デバイス、医薬品、その他）、疾患別（白内障、屈折異常、緑内障、加齢黄斑変性、炎症性疾患、その他）、総合眼科検査（屈折検査、視力検査、眼圧検査、前眼部および瞳孔検査、視野検査、色覚検査、その他）、エンドユーザー別（クリニック、病院、在宅医療、その他）、流通チャネル別（小売販売、直接入札、その他） - 2032年までの業界動向と予測
中東・アフリカの眼科市場分析
中東およびアフリカの眼科市場は、エジプトとギリシャにおける古代の眼疾患治療法に始まり、数世紀にわたり大きく発展してきました。この分野は、より高度な外科手術技術と器具の開発に伴い、17世紀と18世紀に形成され始めました。19世紀には、検眼鏡などの革新が診断能力を変革しました。20世紀には、白内障手術や眼内レンズの発明といった画期的な進歩があり、1990年代にはレーシック手術が導入されました。21世紀は、人口の高齢化、技術の進歩、そして光干渉断層撮影（OCT）や網膜画像システムといった特殊な診断・手術機器の開発に牽引され、継続的な成長を遂げました。近年のトレンドは、人工知能、遠隔医療、そして遺伝子治療や幹細胞治療といった生物学的療法の利用拡大に焦点を当てており、市場の成長をさらに促進しています。今日、眼科市場は、眼疾患の罹患率の上昇、新しい技術、治療オプションの進化により拡大し続けています。
中東およびアフリカの眼科市場規模
中東およびアフリカの眼科市場は、2025年から2032年の予測期間に4.5%のCAGRで成長し、2024年の31億2,000万米ドルから2032年には44億2,000万米ドルに達すると予想されています。
データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、輸出入分析、生産能力概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。
中東およびアフリカの眼科市場動向
「生理食塩水プレフィルドシリンジの安全性と効率性の向上」
中東・アフリカの眼科市場は、眼疾患の増加、技術の進歩、そして人口の高齢化を背景に、堅調な成長を遂げています。白内障、緑内障、糖尿病網膜症、加齢黄斑変性症などの疾患の増加は、眼科治療の需要増加に寄与しています。特に中東・アフリカでは人口の高齢化が進んでおり、高齢者は視力関連の問題を抱えやすいため、この傾向に拍車をかけています。さらに、光干渉断層撮影（OCT）、眼底カメラ、AI搭載システムといった診断技術の進歩により、診断の精度と効率が向上しています。レーザー治療やロボット支援手術といった低侵襲手術技術の人気が高まり、回復期間の短縮と患者の転帰改善が期待されています。さらに、網膜疾患などの疾患に対する標的治療を含む、眼科における個別化医療の発展も重要な役割を果たしています。注射用生物製剤や徐放性インプラントといった新たな薬剤送達システムの導入は、特に慢性疾患の治療効果を向上させています。遠隔診療やバーチャルスクリーニングの普及に伴い、眼科市場における遠隔医療も成長トレンドとなっており、医療サービスが行き届いていない地域における医療へのアクセス向上につながっています。主要市場プレーヤーは製品ポートフォリオの拡充を目指して研究開発に注力する一方、新興市場では手頃な価格で利用しやすい眼科ソリューションへの需要が高まっています。イノベーション、患者ケアの向上、医療アクセスの拡大に重点を置くことで、眼科市場は今後数年間で大幅な成長が見込まれます。
レポートの範囲と中東およびアフリカの眼科市場のセグメンテーション
|
属性 |
中東およびアフリカの眼科市場の洞察 |
|
対象セグメント |
製品別：デバイス、医薬品、その他 疾患別：白内障、屈折異常、緑内障、加齢黄斑変性、炎症性疾患など 総合的な 眼科 検査：屈折検査、視力検査、眼圧検査、前眼部・瞳孔検査、視野検査、色覚検査など エンドユーザー別：診療所、病院、在宅医療、その他 流通 チャネル別：小売販売、直接入札、その他 |
|
対象地域 |
南アフリカ、サウジアラビア、UAE、エジプト、イスラエル、その他の中東およびアフリカ |
|
主要な市場プレーヤー |
Alcon（スイス）、Bausch + Lomb（カナダ）、Carl Zeiss Meditec（ドイツ）、HOYA株式会社（日本）、Johnson & Johnson Services, Inc.（米国）、Essilor International（フランス）、Topcon Corporation（日本）、Glaukos Corporation（米国）、Haag-Streit Group（スイス）、Nidek Co., Ltd（米国）、Staar Surgical（カリフォルニア）、Ziemer Ophthalmic Systems Ag（スイス）、Cooper Companies（米国）、Lumenis Be Ltd.（イスラエル）、Reichert Inc.（ニューヨーク）、Bayer Ag（ドイツ）、Novartis Ag（スイス）、Abbvie Inc.（米国）、F. Hoffmann-La Roche Ltd.（スイス）、Dompé（イタリア）、参天製薬株式会社（日本）など。 |
|
市場機会 |
|
|
付加価値データ情報セット |
データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、輸出入分析、生産能力概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。 |
中東およびアフリカの眼科市場の定義
眼科は、眼の疾患や障害の診断、治療、予防に重点を置いた医学および外科の一分野です。白内障、緑内障、黄斑変性、糖尿病網膜症など、眼や視覚系に影響を与える疾患に対する医学的および外科的治療が含まれます。
中東およびアフリカの眼科市場の定義と動向
ドライバー
ドライバー
- 眼疾患の罹患率の増加
白内障、黄斑変性、糖尿病網膜症といった眼疾患の増加は、中東・アフリカの眼科市場を大きく牽引する要因となっています。中東・アフリカでは人口の高齢化に伴い、これらの疾患の発症率も上昇しています。白内障は視力低下や失明につながるため、手術や矯正治療の市場規模は拡大しています。同様に、黄斑変性と糖尿病網膜症は、高度な診断ツールと専門的な治療法の必要性を高めています。患者数の増加は、手術、投薬、革新的な診断技術を含む眼科サービスへの継続的な需要を保証しています。こうした眼疾患の急増は市場拡大の直接的な原動力となっており、医療提供者とメーカーは効果的な治療法とソリューションへの高まる需要に応えようと努力しています。
例えば、
- 2022年7月、NCBIが発表した論文によると、失明率は加齢とともに上昇し、50～59歳では0.45%であるのに対し、80歳以上では11.62%に増加しています。女性（2.31%）と地方居住者（2.14%）では失明率がさらに高くなっています。視覚障害も26.68%に見られ、同様の傾向を示しています。特に高齢者における眼疾患の増加は、眼科治療と技術の需要を押し上げ、眼科市場を押し上げています。
- 2023年8月、WHO中東アフリカ局が発表した記事によると、22億人以上が視力障害に苦しんでおり、そのうち約10億件は予防可能または未治療です。視力障害の罹患率の増加は、眼科サービス、治療、そして矯正ソリューションに対する需要の高まりを浮き彫りにしています。予防可能または未治療の症状で医療機関を受診する人が増えるにつれ、眼疾患の負担増加は眼科市場の大きな牽引力となっています。
白内障、黄斑変性、糖尿病網膜症といった加齢に伴う眼疾患の増加は、中東・アフリカの眼科市場を牽引しています。人口の高齢化に伴い、これらの疾患はより一般的になり、治療、手術、そして診断ツールへの需要が高まっています。ケアを必要とする人が増えるにつれて、高度な技術と治療法へのニーズも高まります。こうした眼疾患の急増は市場の成長を牽引し、医療提供者とメーカーは効果的なソリューションへの高まる需要に応えようとしています。
- 予防的な目のケアに焦点を当てる
There is a growing emphasis on preventative eye care and early detection of vision-related issues, which is playing a significant role in driving the Middle East and Africa ophthalmology market. As awareness about the importance of eye health increases, more people are seeking routine eye checkups to detect conditions like glaucoma, diabetic retinopathy, and cataracts in their early stages. Early diagnosis allows for timely interventions, reducing the risk of vision loss and improving overall eye health. This proactive approach is not only improving patient outcomes but also fueling demand for ophthalmic services, diagnostic tools, and corrective treatments. The growing focus on preventative care is leading to a surge in investments in eye care technologies, ophthalmic devices, and services, thereby contributing to the market's expansion. This trend strongly acts as a driver for growth in the ophthalmology sector.
For instance,
- In October 2022, according to the article published by National Eye Institute, National Eye Health Education Program(NEHEP) collaborates with health professionals to promote awareness on early detection, treatment of eye diseases, and the benefits of vision rehabilitation. It also targets populations at high risk of eye disease and vision loss. This focus on preventative care encourages people to seek timely eye checkups and treatments, driving demand for ophthalmic services, diagnostic tools, and products, thereby fueling the ophthalmology market
- In October 2024, according to the article published by Directorate General of Health Services, The National Programme for Control of Blindness and Visual Impairment (NPCB&VI) aims to reduce blindness prevalence by identifying and treating curable blindness at all healthcare levels. By focusing on early detection and addressing avoidable blindness, the program highlights the importance of preventative care. This initiative drives demand for eye care services, diagnostic tools, and treatments, contributing significantly to the growth of the Middle East and Africa ophthalmology market
The increasing focus on preventative eye care and early detection is significantly driving the Middle East and Africa ophthalmology market. As awareness of eye health rises, more individuals are opting for routine eye exams to identify conditions like glaucoma and cataracts early. Early detection allows for effective treatments that prevent further vision loss. This proactive approach is driving demand for diagnostic tools, ophthalmic services, and corrective treatments. The growing importance of preventative care is prompting investment in advanced eye care technologies, thus contributing to the overall growth of the ophthalmology market and ensuring its continued expansion.
Opportunities
- Rise in the Aging Population
The rise in the aging population presents a significant opportunity for the Middle East and Africa ophthalmology market, as older individuals are more susceptible to various eye disorders and diseases. Conditions such as cataracts, age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma are prevalent among the elderly, creating a substantial demand for ophthalmic care and treatments. As a result, healthcare systems and ophthalmic providers are poised to expand their services, enhance diagnostic and therapeutic options, and cater to the unique needs of this demographic. This growing patient base necessitates an array of solutions, from surgical interventions and advanced drug therapies to vision correction products, ensuring a steady and increasing demand for ophthalmic procedures and products.
For instance,
- In March 2023, according to an article published in the National Library of Medicine, Cataract is a leading cause of visual impairment in old age. Lens opacification is notoriously associated with several geriatric conditions, including frailty, fall risk, depression and cognitive impairment. Moreover, according to the same source, in 2020, the leading worldwide causes of blindness in patients aged 50 years and older were cataract, followed by glaucoma, under-corrected refractive error, age-related macular degeneration, and diabetic retinopathy
- In August 2022, according to an article published in the American Academy of Ophthalmology, AMD is a common eye disease, usually found in adults over the age of 50. Moreover, it is stated that Half of Americans over the age of 75 develop cataracts
Moreover, addressing the eye health needs of the aging population can stimulate further investments in research and development within the ophthalmology sector. Pharmaceutical companies and medical device manufacturers are focus on creating innovative solutions tailored specifically for age-related conditions, potentially leading to breakthroughs in treatment protocols and patient care. The integration of new technologies, such as tele ophthalmology and advanced imaging techniques, facilitate better management of eye health in older adults, making it easier to monitor and treat conditions remotely. Overall, the aging population amplifies the need for existing ophthalmic services and presents a fertile ground for innovation and growth within the Middle East and Africa ophthalmology market.
- Rise in Online Retail and E-Health Platforms
The rise of online retail and e-health platforms offers a significant opportunity for the Middle East and Africa ophthalmology market by providing consumers with easier access to a wide array of eye care products and services. With the increasing adoption of e-commerce, patients can conveniently purchase items such as prescription glasses, contact lenses, and over-the-counter eye care products from the comfort of their homes. This trend is especially appealing to younger, tech-savvy consumers and those in remote areas with limited access to traditional optical stores. The ability to compare prices, read reviews, and access a wider range of products online enhances customer satisfaction and encourages usage, thereby driving growth in the ophthalmic product segment.
For instance,
- In September 2023, according to a news article from The Times of India, the 'pink eye' outbreak led to a surge in sales of ophthalmology medicine. Sales jumped nearly 30% year-on-year for the second month in a row in August - outgrowing the overall market by almost five times. The rise reflects the massive incidence of conjunctivitis and eye-complications in the last few months across the country
- In April 2020, according to an article, ‘Patient views about online purchasing of eyewear’, online purchasing of contact lenses is on the rise: 10%–20% of contact lens wearers in Australia, U.S. and the UK have considered or researched the possibility of Internet purchasing
In addition to retail opportunities, e-health platforms facilitate telehealth services that allow patients to consult with eye care professionals remotely. Virtual consultations for routine eye examinations, follow-ups, and triaging for more serious conditions can significantly improve access to care, particularly for older adults or individuals with mobility challenges. These platforms enhance patient engagement and adherence to eye health recommendations and allow ophthalmologists to reach a broader patient base without the constraints of geographic boundaries. Furthermore, the integration of digital health tools, such as mobile apps for monitoring eye health or managing chronic conditions, can create a seamless patient experience and foster proactive eye care, further propelling growth in the ophthalmology market.
Restraints/Challenges
- Side Effects and Complications Related to Eye Surgeries
眼科治療は大きく進歩しましたが、特定の眼科処置、特に外科的介入には、感染、瘢痕形成、視力障害といった副作用や合併症のリスクが伴います。これらの潜在的なリスクは、患者が特定の治療、特に侵襲的な処置を伴う治療を躊躇させる要因となります。視力低下や回復期間の長期化といった有害な結果への恐怖は、治療を躊躇させる原因となり、特定の治療法の全体的な導入を阻害する可能性があります。さらに、手術に伴う合併症により追加治療が必要となる場合があり、医療費のさらなる上昇や、先進治療に対する患者の信頼の低下につながります。副作用の可能性を懸念した治療への抵抗感は、新技術や治療法の導入を遅らせ、眼科市場全体の成長を阻害する要因となっています。
例えば、
- ハーバード・ヘルスが2024年10月に発表した記事によると、現代の眼科手術は白内障や緑内障などの症状の治療に効果的である一方で、灼熱感、ざらつき、かゆみを伴うドライアイなどの合併症を引き起こすことが多い。この副作用は患者にとって不快感や不安感をもたらし、眼科手術をためらったり避けたりする原因となっている。結果として、治療に伴う合併症は眼科市場の成長を阻害する要因となっている。
- 2021年7月、Medical News Todayに掲載された記事によると、レーザー眼科手術を受けた人の最大95%がドライアイを経験し、20%がグレアやハローなどの視覚障害を報告しています。さらに、50人に1人がかすみ目や「サハラの砂」症候群に悩まされる可能性があります。これらの副作用は、患者が手術を選択することを躊躇させ、レーザー手術の導入を制限し、眼科市場の成長を阻害する可能性があります。
眼科医療は進歩を遂げていますが、一部の外科治療には感染症、瘢痕、視力障害などのリスクが伴います。これらの合併症は、患者が特定の治療法、特に侵襲的な処置を選択することを躊躇させる要因となっています。副作用や追加治療費への不安は、患者の治療意欲を低下させ、新しい治療法の導入を遅らせる可能性があります。こうした消極的な姿勢が、中東・アフリカの眼科市場の成長を阻害しています。
- 地方における専門的な眼科医療へのアクセスの制限
医療インフラの進歩にもかかわらず、農村部や遠隔地では専門的な眼科医療へのアクセスが依然として限られており、これらの地域における眼科市場の成長ポテンシャルを大きく阻害しています。多くの農村部では、訓練を受けた眼科専門家の不足、設備の不足、高度な診断・治療技術へのアクセスの制限といった課題が依然として存在しています。その結果、これらの地域の人々は、眼疾患の適切な診断と治療を受けるのに苦労することが多く、予防可能な失明や視力障害の発生率が高まっています。専門的なケアへのアクセスが限られているため、高度な眼科ケアサービスや製品の導入が減り、市場拡大が制限されています。こうしたアクセス障壁は、中東およびアフリカの眼科市場全体の成長を阻害する大きな要因となっています。
例えば、
- 2023年2月、NCBIが発表した記事によると、インドの農村人口は膨大で、満たされていない眼科医療ニーズが深刻化しています。医療施設や専門家のほとんどは都市部と準都市部に集中しています。農村部と都市部における眼科医療へのアクセス格差は依然として課題であり、治療へのアクセスが制限されています。この医療資源の不平等な配分は、農村部における必須サービスへの広範なアクセスを阻害し、中東およびアフリカの眼科市場の成長を阻害しています。
- 2024年3月、リサーチゲートが発表した記事によると、「遠隔地では、インターネット接続や訓練を受けたスタッフが不足しているため、眼科キャンプが成功した後でも、継続的な眼科ケアへのアクセスが妨げられています。これらの地域の患者は、適切なインフラが整備されていないため、フォローアップケアや高度な治療を受けるのに苦労しています。この医療提供のギャップは、眼科ケアプログラムの範囲と効果を制限し、中東およびアフリカの眼科市場の成長を阻害しています。」
医療体制の改善にもかかわらず、地方では専門的な眼科医療へのアクセスが依然として限られています。眼科医療従事者、高度な技術、そして設備の不足により、適切な治療と診断が受けられず、回避可能な失明率の上昇につながっています。こうしたアクセスの制限は、これらの地域における高度な治療とサービスの導入を制限し、中東・アフリカの眼科市場の成長を阻害しています。
中東およびアフリカの眼科市場の範囲
市場は、製品、疾患、総合眼科検査、エンドユーザー、流通チャネルに基づいてセグメント化されています。これらのセグメント間の成長は、業界における成長の少ないセグメントの分析に役立ち、ユーザーに貴重な市場概要と市場洞察を提供し、コア市場アプリケーションを特定するための戦略的意思決定を支援します。
製品別
- デバイス
- 外科用デバイス
- 白内障手術器具
- 眼科用粘弾性デバイス
- 超音波乳化吸引装置
- 白内障手術用レーザー
- IOLインジェクター
- 硝子体網膜手術デバイス
- 硝子体切除術装置
- Vitreoretinal Packs
- Photocoagulation Lasers
- Vitrectomy Probes
- Illumination Devices
- Refractive Surgical Devices
- Femtosecond Lasers
- Excimer Lasers
- Other Refractive Surgical Lasers
- Glaucoma Surgical Devices
- Glaucoma Drainage Devices
- Microinvasive Glaucoma Surgery Devices
- Glaucoma Laser Systems
- Diagnostic Device
- Optical Coherence Tomography (OCT) Scanners
- Autorefractors & Keratometers
- Tonometers
- Phoropters
- Retinoscopes
- Ophthalmoscopes
- Slit lamps
- Perimeters/Visual Field Analyzers
- Corneal Topography Systems
- Fundus Cameras
- Ophthalmic Ultrasound Imaging Systems
- A- Scan Imaging System
- B-Scan Imaging System
- Pachymeters
- Ultrasound Biomicroscopes
- Lensmeters
- Wavefront Aberrometers
- Optical biometry Systems
- Specular Microscopes
- Chart Projectors
- Ophthalmic Surgical Accessories
- Surgical Instruments & Kits
- Ophthalmic Forceps
- Ophthalmic Spatula
- Ophthalmic Tips and Handles
- Ophthalmic Cannulas
- Ophthalmic Scissors
- Others Surgical Accessories
- Ophthalmic Microscopes
- 外科用デバイス
- Drugs, By Products
- Anti-VEGF Drugs
- Ranibizumab
- Bevacizumab
- Retinal Disorder Drugs
- Anti-Glaucoma Drugs
- Prostaglandin Analogs
- Latanoprost
- Bimatoprost
- Travoprost
- Tafluprost
- Latanoprostene
- BETA Adrenergic Antagonists
- Timolal Maleate
- Betaxolol
- Alpha Adrenergic Agonists
- Epinephrine
- Depiveprine
- Miotics
- Pilocarpine
- Eserine
- Prostaglandin Analogs
- Dry Eye Drugs
- Anti-Inflammatory Drugs
- Steroidal anti-Inflammatory Drugs
- Non-steroidal Anti-Inflammatory Drugs
- Allergic Conjuctivitis Drugs
- Others
- Anti-VEGF Drugs
- Drugs, By Drug Type
- Branded
- Generic
- Drugs, By Presciption Mode
- Prescription
- Over the Counter
- Drugs, By Route of Administration
- Topical
- Eye Drops
- Eye Solution
- Cream & Ointments
- Gel
- Others
- Local Ocular
- Intravitreal
- Subconjunctival
- Retrobulbar
- Intracameral
- Injectables
- Intramuscular
- Intravenous
- Others
- Oral
- Tablet
- Capsules
- Others
- Others
- Topical
- Others
- Vision Care Products
- Spectacles
- Contact Lenses
- Soft Contact Lenses
- Hybrid Contact Lenses
- Rigid Gas Permeable Lenses
- Others
- Vision Care Products
By Diseases
- Cataract
- Refractive Disorders
- Glaucoma
- Age-related Macular Degeneration
- Inflammatory Diseases
- Others
By Comprehensive Eye Examination
- Refraction
- Automated Refractometers
- Set of Trial Lenses
- Cycloplegic Drugs
- Trial Frame
- Self-Illuminated/ Mirror Retinoscope
- Jackson Cross Cylinder
- Visual Acuity Test
- Snellen's Chart
- Near Vision Charts
- Intraocular Pressure
- Tonometers (Goldmann, Tono-Pen, Perkins, Shiotz)
- Others
- Anterior Segment and Pupillary Examination
- Slit Lamp Biomicroscope
- Torch Light
- Visual Fields Test
- Central 30-2 Full Threshold Humphrey Visual Field Analyzer
- Frequency Doubling Perimeter
- Goldmann Kinetic Perimeter
- Color Vision Test
- Others
By End User
- Clinics
- Hospitals
- Home Healthcare
- Others
By Distribution Channel
- Retail sales
- Retail Shops
- Hospital Pharmacy
- Online Pharmacy
- Direct Tender
- Others
Middle East and Africa Ophthalmology Market Regional Analysis
The market is segmented on the basis of products, diseases, comprehensive eye examination, end user, and distribution channel.
The countries covered in the market are South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East and Africa.
South Africa is expected to be dominate & fastest growing in the market due to advanced healthcare infrastructure, high healthcare spending, and a large aging population with a growing prevalence of eye diseases. Additionally, significant investments in research, development, and the adoption of cutting-edge technologies drive market leadership in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Middle East and Africa Ophthalmology Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Middle East and Africa Ophthalmology Market Leaders Operating in the Market Are:
- Alcon (Switzerland)
- Bausch + Lomb (Canada)
- Carl Zeiss Meditec( Germany)
- Hoya Corporation (Japan)
- Johnson & Johnson Services, Inc. (U.S.)
- Essilor International (France)
- Topcon Corporation(Japan)
- Glaukos Corporation (U.S.)
- Haag-Streit Group (Switzerland)
- Nidek Co., Ltd (U.S.)
- Staar Surgical (California)
- Ziemer Ophthalmic Systems Ag (Switzerland)
- Cooper Companies (U.S.)
- Lumenis Be Ltd. (Israel)
- Reichert Inc. (New York)
Latest Developments in Middle East and Africa Ophthalmology Market
- In October 2024, At the AAO 2024 meeting, Alcon showcased its innovations, including the Voyager DSLT for glaucoma treatment, UNIFEYE and UNIPEXY handheld gas delivery systems, and pivotal data for AR-15512, a dry eye treatment. These advancements aimed to improve outcomes and surgical efficiency
- In September 2024, EssilorLuxottica and Meta have extended their partnership, entering a long-term agreement to develop multi-generational smart eyewear products. Building on the success of Ray-Ban Meta glasses, the companies aim to shape the future of wearable technology together
- In OCTOBER 2024, Bausch + Lomb presented new scientific data and educational events at the 2024 AAO meeting in Chicago. Highlights included studies on the enVista Envy IOL, TENEO Excimer Laser, VYZULTA, and presentations on Blink Nutritears, MIEBO, and Xiidra
- In April 2024, AbbVie has completed its acquisition of Cerevel Therapeutics, enhancing its neuroscience portfolio. The acquisition includes Cerevel’s promising clinical-stage assets like Emraclidine for schizophrenia and Tavapadon for Parkinson's disease, strengthening AbbVie’s position in neurology and psychiatry
- In September, 2023, Novartis completed the divestment of its 'front of eye' ophthalmology assets to Bausch + Lomb for up to USD 2.5 billion, including USD 1.75 billion in upfront cash and potential milestone payments. The deal included Xiidra, SAF312, AcuStream, and OJL332. Novartis advanced its strategy to focus on prioritized therapeutic areas for future growth
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET : REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF EYE DISEASES
6.1.2 FOCUS ON PREVENTATIVE EYE CARE
6.1.3 GOVERNMENT EYECARE INITIATIVES
6.1.4 INNOVATIONS IN OPHTHALMIC SURGICAL TECHNIQUES
6.2 RESTRAINTS
6.2.1 SIDE EFFECTS AND COMPLICATIONS RELATED TO EYE SURGERIES
6.2.2 LIMITED ACCESS TO SPECIALIZED OPHTHALMIC CARE IN RURAL AREAS
6.3 OPPORTUNITIES
6.3.1 RISE IN THE AGING POPULATION
6.3.2 RISE IN ONLINE RETAIL AND E-HEALTH PLATFORMS
6.3.3 ENHANCED PATIENT EDUCATION
6.4 CHALLENGES
6.4.1 RISING COSTS OF OPHTHALMIC TREATMENTS
6.4.2 SHORTAGE OF EYE CARE PROFESSIONALS
7 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKETMIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS
7.1 OVERVIEW
7.2 DEVICE
7.2.1 SURGICAL DEVICE
7.2.1.1 CATARACT SURGICAL DEVICES
7.2.1.2 OPHTHALMIC VISCOELASTIC DEVICES
7.2.1.2.1 PHACOEMULSIFICATION DEVICES
7.2.1.2.2 CATARACT SURGICAL LASERS
7.2.1.2.3 IOL INJECTORS
7.2.1.3 VITREORETINAL SURGICAL DEVICES
7.2.1.3.1 VITREORETINAL PACKS
7.2.1.3.2 VITRECTOMY MACHINES
7.2.1.3.3 VITRECTOMY PROBES
7.2.1.3.4 PHOTOCOAGULATION LASERS
7.2.1.3.5 ILLUMINATION DEVICES
7.2.1.4 REFRACTIVE SURGICAL DEVICES
7.2.1.4.1 FEMTOSECOND LASERS
7.2.1.4.2 EXCIMER LASERS
7.2.1.4.3 OTHER REFRACTIVE SURGICAL LASERS
7.2.1.5 GLAUCOMA SURGICAL DEVICES
7.2.1.5.1 GLAUCOMA DRAINAGE DEVICES
7.2.1.5.2 GLAUCOMA LASER SYSTEMS
7.2.1.5.3 MICRO INVASIVE GLAUCOMA SURGERY DEVICES
7.2.2 DIAGNOSTIC DEVICE
7.2.2.1 OPTICAL COHERENCE TOMOGRAPHY (OCT) SCANNERS
7.2.2.2 AUTOREFRACTORS & KERATOMETERS
7.2.2.3 TONOMETERS
7.2.2.4 PHOROPTERS
7.2.2.5 RETINOSCOPES
7.2.2.6 OPHTHALMOSCOPES
7.2.2.7 SLIT LAMPS
7.2.2.8 PERIMETERS/VISUAL FIELD ANALYZERS
7.2.2.9 CORNEAL TOPOGRAPHY SYSTEMS
7.2.2.10 FUNDUS CAMERAS
7.2.2.11 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
7.2.2.11.1 A- SCAN IMAGING SYSTEM
7.2.2.11.2 B-SCAN IMAGING SYSTEM
7.2.2.11.3 PACHYMETERS
7.2.2.11.4 ULTRASOUND BIOMICROSCOPES
7.2.2.12 LENSMETERS
7.2.2.13 WAVEFRONT ABERROMETERS
7.2.2.14 OPTICAL BIOMETRY SYSTEMS
7.2.2.15 SPECULAR MICROSCOPES
7.2.2.16 CHART PROJECTORS
7.2.3 OPHTHALMIC SURGICAL ACCESSORIES
7.2.3.1 SURGICAL INSTRUMENTS & KITS
7.2.3.2 OPHTHALMIC FORCEPS
7.2.3.3 OPHTHALMIC SPATULA
7.2.3.4 OPHTHALMIC TIPS AND HANDLES
7.2.3.5 OPHTHALMIC CANNULAS
7.2.3.6 OPHTHALMIC SCISSORS
7.2.3.7 OTHERS SURGICAL ACCESSORIES
7.2.4 OPHTHALMIC MICROSCOPES
7.3 DRUGS
7.3.1 ANTI-VEGF DRUGS
7.3.1.1 RANIBIZUMAB
7.3.1.2 BEVACIZUMAB
7.3.2 ANTI-GLAUCOMA DRUGS
7.3.2.1 PROSTAGLANDIN ANALOGS
7.3.2.1.1 LATANOPROST
7.3.2.1.2 BIMATOPROST
7.3.2.1.3 TRAVOPROST
7.3.2.1.4 TAFLUPROST
7.3.2.1.5 LATANOPROSTENE
7.3.2.2 BETA ADRENERGIC ANTAGONISTS
7.3.2.2.1 TIMOLAL MALEATE
7.3.2.2.2 BETAXOLOL
7.3.2.3 ALPHA ADRENERGIC AGONISTS
7.3.2.3.1 EPINEPHRINE
7.3.2.3.2 DEPIVEPRINE
7.3.2.4 MIOTICS
7.3.2.4.1 PILOCARPINE
7.3.2.4.2 ESERINE
7.3.3 ANTI-INFLAMMATION DRUGS
7.3.3.1 STEROIDAL ANTI-INFLAMMATORY DRUGS
7.3.3.2 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
7.3.4 RETINAL DISORDER DRUGS
7.3.5 DRY EYE DRUGS
7.3.6 ALLERGIC CONJUCTIVITIS DRUGS
7.3.7 OTHERS
7.3.7.1 BRANDED
7.3.7.2 GENERIC
7.3.7.3 PRESCRIPTION
7.3.7.4 OVER THE COUNTER
7.3.7.5 TOPICAL
7.3.7.6 LOCAL OCULAR
7.3.7.7 INJECTABLES
7.3.7.8 ORAL
7.3.7.9 OTHERS
7.3.7.10 EYE DROPS
7.3.7.11 EYE SOLUTION
7.3.7.12 CREAM & OINTMENTS
7.3.7.13 GEL
7.3.7.14 OTHERS
7.3.7.15 INTRAVITREAL
7.3.7.16 SUBCONJUNCTIVAL
7.3.7.17 RETROBULBAR
7.3.7.18 INTRACAMERAL
7.3.7.19 INTRAMUSCULAR
7.3.7.20 INTRAVENOUS
7.3.7.21 OTHERS
7.3.7.22 TABLET
7.3.7.23 CAPSULES
7.3.7.24 OTHERS
7.4 OTHERS
7.4.1 VISION CARE PRODUCTS
7.4.1.1 SPECTACLES
7.4.1.2 CONTACT LENSES
7.4.1.2.1 SOFT CONTACT LENSES
7.4.1.2.2 HYBRID CONTACT LENSES
7.4.1.2.3 RIGID GAS PERMEABLE LENSES
7.4.2 OTHERS
8 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY DISEASES
8.1 OVERVIEW
8.2 CATARACT
8.3 REFRACTIVE DISORDERS
8.4 GLAUCOMA
8.5 AGE-RELATED MACULAR DEGENERATION
8.6 INFLAMMATORY DISEASES
8.7 OTHERS
9 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION
9.1 OVERVIEW
9.2 REFRACTION
9.2.1 AUTOMATED REFRACTOMETERS
9.2.2 SET OF TRIAL LENSES
9.2.3 CYCLOPLEGIC DRUGS
9.2.4 TRIAL FRAME
9.2.5 SELF-ILLUMINATED/ MIRROR RETINOSCOPE
9.2.6 JACKSON CROSS CYLINDER
9.3 VISUAL ACUITY TEST
9.3.1 SNELLEN'S CHART
9.3.2 NEAR VISION CHARTS
9.4 INTRAOCULAR PRESSURE
9.4.1 TONOMETERS (GOLDMANN, TONO-PEN, PERKINS, SHIOTZ)
9.4.2 OTHERS
9.5 ANTERIOR SEGMENT AND PUPILLARY EXAMINATION
9.5.1 SLIT LAMP BIOMICROSCOPE
9.5.2 TORCH LIGHT
9.6 VISUAL FIELDS TEST
9.6.1 CENTRAL 30-2 FULL THRESHOLD HUMPHREY VISUAL FIELD ANALYZER
9.6.2 FREQUENCY DOUBLING PERIMETER
9.6.3 GOLDMANN KINETIC PERIMETER
9.7 COLOR VISION TEST
9.8 OTHERS
10 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY END USER
10.1 OVERVIEW
10.2 CLINICS
10.3 HOSPITALS
10.4 HOME HEALTHCARE
10.5 OTHERS
11 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 RETAIL SALES
11.2.1 RETAIL SHOPS
11.2.2 HOSPITAL PHARMACY
11.2.3 ONLINE PHARMACY
11.3 DIRECT TENDER
11.4 OTHERS
12 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET BY GEOGRAPHY
12.1 MIDDLE EAST AND AFRICA
12.1.1 SOUTH AFRICA
12.1.2 SAUDI ARABIA
12.1.3 U.A.E
12.1.4 EGYPT
12.1.5 ISRAEL
12.1.6 REST OF MIDDLE EAST AND AFRICA
13 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 ALCON
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 JOHNSON & JOHNSON SERVICES, INC.
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 ESSILOR LUXOTTICA
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 NOVARTIS AG
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 BAUSCH + LOMB
15.5.1 COMPANY SNAPSHOT
15.5.2 COMPANY SHARE ANALYSIS
15.5.3 REVENUE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 ABBVIE INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BAYER AG
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 CARL ZEISS MEDITEC AG
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENT
15.9 COOPER COMPANIES
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.1 DOMPÉ
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 F. HOFFMANN-LA ROCHE LTD
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 GLAUKOS CORPORATION
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 HAAG-STREIT
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 HOYA CORPORATION
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUE ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENT
15.15 LUMENIS BE LTD.
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 NIDEK CO.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 REICHERT, INC
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENT
15.18 SANTEN PHARMACEUTICAL CO.
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENT
15.19 STAAR SURGICAL
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENT
15.2 TOPCON CORPORATION
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENT
15.21 ZIEMER OPHTHALMIC SYSTEMS AG
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
表のリスト
TABLE 1 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA ANTI INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA CATARACT IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA REFRACTIVE DISORDERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA GLAUCOMA IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA AGE-RELATED MACULAR DEGENERATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA INFLAMMATORY DISEASES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA REFRACTION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA COLOR VISION TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA CLINICS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA HOSPITALS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA HOME HEALTHCARE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 56 MIDDLE EAST AND AFRICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 57 MIDDLE EAST AND AFRICA DIRECT TENDER IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 58 MIDDLE EAST AND AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 59 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 61 MIDDLE EAST AND AFRICA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 62 MIDDLE EAST AND AFRICA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 63 MIDDLE EAST AND AFRICA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 64 MIDDLE EAST AND AFRICA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 65 MIDDLE EAST AND AFRICA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 66 MIDDLE EAST AND AFRICA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 67 MIDDLE EAST AND AFRICA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 68 MIDDLE EAST AND AFRICA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 69 MIDDLE EAST AND AFRICA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 70 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 71 MIDDLE EAST AND AFRICA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 72 MIDDLE EAST AND AFRICA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 73 MIDDLE EAST AND AFRICA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 74 MIDDLE EAST AND AFRICA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 75 MIDDLE EAST AND AFRICA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 76 MIDDLE EAST AND AFRICA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 77 MIDDLE EAST AND AFRICA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 78 MIDDLE EAST AND AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 79 MIDDLE EAST AND AFRICA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 80 MIDDLE EAST AND AFRICA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 81 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 82 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 83 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 84 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 85 MIDDLE EAST AND AFRICA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 86 MIDDLE EAST AND AFRICA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 87 MIDDLE EAST AND AFRICA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 88 MIDDLE EAST AND AFRICA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 89 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 90 MIDDLE EAST AND AFRICA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 91 MIDDLE EAST AND AFRICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 92 MIDDLE EAST AND AFRICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 93 MIDDLE EAST AND AFRICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 94 MIDDLE EAST AND AFRICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 95 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 96 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97 MIDDLE EAST AND AFRICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 98 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 99 SOUTH AFRICA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 100 SOUTH AFRICA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 101 SOUTH AFRICA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 102 SOUTH AFRICA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 103 SOUTH AFRICA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 104 SOUTH AFRICA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 105 SOUTH AFRICA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 106 SOUTH AFRICA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 107 SOUTH AFRICA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 108 SOUTH AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 109 SOUTH AFRICA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 110 SOUTH AFRICA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 111 SOUTH AFRICA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 112 SOUTH AFRICA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 113 SOUTH AFRICA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 114 SOUTH AFRICA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 115 SOUTH AFRICA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 116 SOUTH AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 117 SOUTH AFRICA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 118 SOUTH AFRICA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 119 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 120 SOUTH AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 121 SOUTH AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 122 SOUTH AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 123 SOUTH AFRICA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 124 SOUTH AFRICA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 125 SOUTH AFRICA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 126 SOUTH AFRICA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 127 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 128 SOUTH AFRICA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 129 SOUTH AFRICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 130 SOUTH AFRICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 131 SOUTH AFRICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 132 SOUTH AFRICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 133 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 134 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135 SOUTH AFRICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 136 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 137 SAUDI ARABIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 138 SAUDI ARABIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 139 SAUDI ARABIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 140 SAUDI ARABIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 141 SAUDI ARABIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 142 SAUDI ARABIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 143 SAUDI ARABIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 144 SAUDI ARABIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 145 SAUDI ARABIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 146 SAUDI ARABIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 147 SAUDI ARABIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 148 SAUDI ARABIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 149 SAUDI ARABIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 150 SAUDI ARABIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 151 SAUDI ARABIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 152 SAUDI ARABIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 153 SAUDI ARABIA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 154 SAUDI ARABIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 155 SAUDI ARABIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 156 SAUDI ARABIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 157 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 158 SAUDI ARABIA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 159 SAUDI ARABIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 160 SAUDI ARABIA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 161 SAUDI ARABIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 162 SAUDI ARABIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 163 SAUDI ARABIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 164 SAUDI ARABIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 165 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 166 SAUDI ARABIA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 167 SAUDI ARABIA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 168 SAUDI ARABIA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 169 SAUDI ARABIA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 170 SAUDI ARABIA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 171 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 172 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173 SAUDI ARABIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 174 U.A.E OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 175 U.A.E DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 176 U.A.E SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 177 U.A.E OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 178 U.A.E VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 179 U.A.E REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 180 U.A.E GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 181 U.A.E DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 182 U.A.E OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 183 U.A.E OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 184 U.A.E DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 185 U.A.E ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 186 U.A.E ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 187 U.A.E PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 188 U.A.E BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 189 U.A.E ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 190 U.A.E MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 191 U.A.E ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 192 U.A.E OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 193 U.A.E VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 194 U.A.E CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 195 U.A.E OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 196 U.A.E DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 197 U.A.E DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 198 U.A.E DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 199 U.A.E TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 200 U.A.E LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 201 U.A.E INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 202 U.A.E ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 203 U.A.E OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 204 U.A.E REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 205 U.A.E VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 206 U.A.E INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 207 U.A.E ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 208 U.A.E VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 209 U.A.E OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 210 U.A.E OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 211 U.A.E RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 212 EGYPT OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 213 EGYPT DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 214 EGYPT SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 215 EGYPT OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 216 EGYPT VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 217 EGYPT REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 218 EGYPT GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 219 EGYPT DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 220 EGYPT OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 221 EGYPT OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 222 EGYPT DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 223 EGYPT ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 224 EGYPT ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 225 EGYPT PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 226 EGYPT BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 227 EGYPT ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 228 EGYPT MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 229 EGYPT ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 230 EGYPT OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 231 EGYPT VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 232 EGYPT CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 233 EGYPT OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 234 EGYPT DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 235 EGYPT DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 236 EGYPT DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 237 EGYPT TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 238 EGYPT LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 239 EGYPT INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 240 EGYPT ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 241 EGYPT OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 242 EGYPT REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 243 EGYPT VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 244 EGYPT INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 245 EGYPT ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 246 EGYPT VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 247 EGYPT OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 248 EGYPT OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 249 EGYPT RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 250 ISRAEL OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 251 ISRAEL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 252 ISRAEL SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 253 ISRAEL OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 254 ISRAEL VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 255 ISRAEL REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 256 ISRAEL GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 257 ISRAEL DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 258 ISRAEL OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 259 ISRAEL OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 260 ISRAEL DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 261 ISRAEL ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 262 ISRAEL ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 263 ISRAEL PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 264 ISRAEL BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 265 ISRAEL ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 266 ISRAEL MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 267 ISRAEL ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 268 ISRAEL OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 269 ISRAEL VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 270 ISRAEL CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 271 ISRAEL OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 272 ISRAEL DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 273 ISRAEL DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 274 ISRAEL DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 275 ISRAEL TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 276 ISRAEL LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 277 ISRAEL INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 278 ISRAEL ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 279 ISRAEL OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 280 ISRAEL REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 281 ISRAEL VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 282 ISRAEL INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 283 ISRAEL ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 284 ISRAEL VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 285 ISRAEL OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 286 ISRAEL OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 287 ISRAEL RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 288 REST OF MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
図表一覧
FIGURE 1 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: SEGMENTATION
FIGURE 11 THREE SEGMENTS COMPRISE THE MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 RISING INCIDENCE OF EYE DISORDERS IS DRIVING THE GROWTH OF THE MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET FROM 2025 TO 2032
FIGURE 15 THE PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET IN 2025 AND 2032
FIGURE 16 DROC ANALYSIS
FIGURE 17 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY PRODUCTS, 2024
FIGURE 18 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY PRODUCTS, 2025-2032 (USD MILLION)
FIGURE 19 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY PRODUCTS, CAGR (2025-2032)
FIGURE 20 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY PRODUCTS, LIFELINE CURVE
FIGURE 21 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISEASES, 2024
FIGURE 22 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISEASES, 2025-2032 (USD MILLION)
FIGURE 23 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISEASES, CAGR (2025-2032)
FIGURE 24 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISEASES, LIFELINE CURVE
FIGURE 25 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2024
FIGURE 26 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2025-2032 (USD MILLION)
FIGURE 27 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, CAGR (2025-2032)
FIGURE 28 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, LIFELINE CURVE
FIGURE 29 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY END USER, 2024
FIGURE 30 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY END USER, 2025-2032 (USD MILLION)
FIGURE 31 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY END USER, CAGR (2025-2032)
FIGURE 32 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY END USER, LIFELINE CURVE
FIGURE 33 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL ,2024
FIGURE 34 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
FIGURE 35 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)
FIGURE 36 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 37 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET SNAPSHOT
FIGURE 38 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: COMPANY SHARE 2024 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
